Ultrasolv syrup 120 ml

Tradename

Ultrasolve

Ultrasolv

Composition

Each 5 ml of syrup contains:

Carbocisteine 125mg

Guaifenazine 100 mg

Oxomemazine hydrochloride 2 mg

Auxiliary components:

Sodium bicarbonate, sucrose, sodium methyl paraben, sodium propyl paraben, sodium saccharin, caramel flavor, sorbitol, purified water.

Properties

Carbocisteine

Mucolytic and expectorant drug. Mucolytic and expectorant action is due to the activation of sialic transferase — an enzyme of the goblet cells of the bronchial mucosa. Normalizes the quantitative ratio of acidic and neutral sialomucins of bronchial secretions. Reduces the viscosity of bronchial secretions and discharge from the paranasal sinuses, facilitates the discharge of sputum and mucus, and reduces coughing. Promotes regeneration of the mucous membrane, normalizes its structure, activates the activity of the ciliated epithelium. Restores the secretion of lgA immunoglobulin (specific protection) and the number of sulfhydryl groups of mucus components (non-specific protection), improves mucociliary clearance.

Guaifenazine

Indications

acute and chronic bronchopulmonary diseases, accompanied by the formation of viscous, difficult to separate sputum (tracheitis, bronchitis, tracheobronchitis, bronchial asthma, bronchiectasis);

-inflammatory diseases of the middle ear (otitis media);

-inflammatory diseases of the nose and its paranasal sinuses (rhinitis, sinusitis);

Contraindications

-increased sensitivity to carbocisteine and other components of the drug;

peptic ulcer of the stomach and duodenum in the acute phase;

chronic glomerulonephritis in the acute phase;

Side effects

From the digestive system: sometimes nausea, vomiting, diarrhea, epigastric pain, gastrointestinal bleeding.

Allergic reactions: in isolated cases — itching, urticaria, exanthema, angioedema.

Others: dizziness, weakness, malaise.